AstraZeneca’s olaparib may also work in prostate cancer -expert

AstraZeneca’s olaparib might likewise operate in prostate cancer -professional Today – 17:13 GMT LONDON, Nov 4 (Reuters) – AstraZeneca’s brand-new cancer drug olaparib, which won a thumbs-up from European regulators prior month for inherited ovarian cancer cells, might also be gooded far more commonly to address prostate cancer, according to [...] Read More